Milking the Genome
By Britt Bailey
Meet "Cookies" and "Cream." No, this is not an invitation
to try a yummy ice cream flavor. These are the names of two members of a cloned
dairy herd. They are exact replicas of each other. Unlike human twins which
carry a random sampling of identical genes, these cattle carry a matching
set of genes which have been designed to produce various types of pharmaceutical
products. Once the calves are old enough, the engineered proteins in their
milk will be mined and hopefully processed for drug testing.
According to researchers, this model is fully justified on the grounds
that we already expend precious time and resources trying to produce pharmaceuticals
through synthesis and purification. With 100% efficiency, the cloned offspring
of a suitably engineered transgenic animal could in theory produce a herd
of lactating descendents, all making one, high value-added product. The savings
in reproductive time can be astounding: milk-producing, cloned cows can be
made in a mere two years. Of course, another added benefit is the ability
to select and implant only the sought-after traits instead of fiddling around
with the imprecise, time-honored practice of traditional breeding.
Historically, most breeding applications, traditional or otherwise, have
sought to improve lineages of animals and plants to better fit our needs.
But, the sheer rush to transform animals for greater utility should give us
pause. Persons who partake of animal products are beginning to opt for more
humane care in the rearing of livestock. Should we accept the complete control
and supremacy over the genetic nature of livestock? Keep in mind that once
controlled via inserted genetic sequences, the change in an engineered animal
and all its descendents is permanent. In the past, even though an animal was
part of a captive breeding program, the changes imposed by human selection
were limited by the genetic repertoire of the species. Now an engineered animal
may be forever altered with totally alien genes for the sake of medical progress,
efficiency, added value, and ultimately corporate profit.
If we are going to eat from an animal source most of us would probably
prefer to know exactly where the animal was reared. Perhaps we would find
some relief knowing it had a good life on a small farm where it grazed on
lush green hillsides. Even the staunchest meat eaters may be troubled by stories
of disease-ridden slaughterhouses and feedlots coupled with media stories
highlighting outbreaks of food-borne illness. But, what does it mean when
we begin to genetically alter animals, not solely to provide larger fillets,
but to provide sources of human drugs and perhaps even organs?
Some companies, such as Infigen and Advanced Cell Technologies, are leading
the rush towards animal "pharming". While certain obstacles, albeit impermanent
ones, have been put in the way of using public funds to clone or conduct germ
line alteration research, the research and manufacturing of cloned and genetically
modified fauna in the private sector is occurring at breakneck speed.
Infigen, a privately held biotechnology company, is at the forefront
of the attempts to enhance agriculture and human health using molecular reproductive
technologies. Their aims span everything from drugs to better mozzarella cheese
for your pizza. In the not so distant future, farmers will be able to attend
their favorite mid-western dairy shows and choose from a glut of cloned heifers
designed to churn out everything from monoclonal antibodies to specialty cheeses.
Even so-called natural products could be over-produced. Any calf having a
particularly high-value based end product could be cloned, producing a whole
herd capable of manufacturing any desired product, be it Factor VIII
to treat hemophilia or just your favorite specialty cheeses.
In the cloned livestock world to be, a farmer could clone a herd of cattle
which yield epicurean extra sharp cheddar and then distinguish his herd's
consumptive product by giving it an appellation much like those conferred
on a high quality wine growing region. Given the public's general suspicion
towards genetics, I doubt we would find a cheese labeled µ-1,3 EX, however
we may be able to purchase Charlene's Consummate Cheddar. Of course, the
cheese would be from Charlene the Holstein, and her many identical elves all
working in factory fashion, churning out cheese using the most efficient and
predictable technology of the time.
That we have reached a point in our American Zeitgeist where we collectively
reorganize the genetic structure of our animals (and soon ourselves) is both
our greatest technical achievement and perhaps our greatest flaw. We have
long acknowledged the influence of environment on our beings. But what if
we begin simultaneously changing the internal and external world at the same
time? Even as we become infatuated with self-propagating techniques for mice,
cows, and even rare endangered species, we fail to remember a fundamental
maxim: the exceptionality of all organisms rests in the uniqueness of their
constitutions. Even if you can morally accept the transmogrification of the
structures of livestock for human purposes, whatever they may be, we must
wonder if we are truly improving upon nature. When we clone herds and flocks
of animals identical in the composition, we are creating organisms that are
stagnant in their ability to adapt to environmental or evolutionary change.
In doing so, we may be creating an evolutionary end-game. The trade-off for
an ultimate goal of predictability and precision, may well be evolutionary
stasisóand who said we were ready to
be finished with creation. One can only wonder how long it will be before
our attempts to simplify complex beings through genetic engineering gets the
better of us.
|